Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TREOSULFAN for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 17 adverse event reports in the FDA FAERS database where TREOSULFAN was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for TREOSULFAN

Side Effect Reports % Deaths Hosp.
Off label use 418 24.4% 81 53
Cytomegalovirus infection 211 12.3% 18 10
Mucosal inflammation 199 11.6% 34 36
Cytomegalovirus infection reactivation 190 11.1% 18 20
Adenovirus infection 168 9.8% 41 19
Product use in unapproved indication 161 9.4% 23 18
Acute graft versus host disease in skin 145 8.5% 25 18
Drug ineffective 117 6.8% 26 27
Graft versus host disease in skin 109 6.4% 17 9
Human herpesvirus 6 infection 104 6.1% 13 7
Neutropenia 94 5.5% 10 2
Multiple organ dysfunction syndrome 91 5.3% 81 26
Acute graft versus host disease 90 5.3% 7 17
Pyrexia 84 4.9% 18 39
Graft versus host disease in gastrointestinal tract 80 4.7% 19 16

Other Indications for TREOSULFAN

Bone marrow conditioning regimen (695) Allogenic stem cell transplantation (397) Prophylaxis against transplant rejection (136) Stem cell transplant (108) Immunosuppressant drug therapy (76) Prophylaxis against graft versus host disease (58) Product used for unknown indication (56) Immunosuppression (46) Acute myeloid leukaemia (38) Sickle cell disease (36)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

TREOSULFAN Full Profile All Diffuse large b-cell lymphoma Drugs TREOSULFAN Demographics TREOSULFAN Timeline